leisure time -WSS

leisure time

author：hotspot 2025-09-29 07:35:24 - browse：3

Powdered ibogaine against a white background. — Tabernanthe iboga, the shrub that contains the psychedelic substance ibogaine. Wikimedia Commons

The psychedelic ibogaine is unlikely to ever receive approval as a treatment for opioid addiction, the federal government’s top addiction researcher said Thursday.

The remarks from Nora Volkow, the longtime director of the National Institute on Drug Abuse, serve as a cautionary note amid widespread enthusiasm about ibogaine, a naturally occurring substance that drug companies and researchers have increasingly cast as a potential paradigm-shifting addiction treatment.

But its potential cardiac side effects could stand in the way of receiving approval from the Food and Drug Administration, Volkow said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Software glitch causes Tandem insulin pump to shutdown, FDA warns

WSS

Steward Health Care files for bankruptcy

Ionis drug prevents swelling attacks due to hereditary angioedema

BMI, flaws aside, is found to be useful estimate of body fat in youth

H5N1 communication has been strictly for the birds

Use wet bulb globe temperature, not heat index, to protect workers

Innovation in antibiotics is ailing. 'Brain drain' may kill it

hotspot

leisure time

focus

Virginia high school admissions case could be legal follow

At ASCO, AstraZeneca reports strong data for breast cancer drug

Dobbs anniversary: the lost opportunity of abortion as health care

Apple Watch's A

State Dept. review finds Biden bears some blame for Afghanistan failures

See how much Covid

The high cost of giving birth even with insurance

The Pandemic Treaty must support building strong health systems

In age of alternative facts, a scholarly course on calling out crap

Intellia reports positive results for its CRISPR

focus

Study: Adult vaccinations pay for themselves in societal benefits

NIH documents show early flaws of $1.6 billion long Covid program

Brain worms: The science behind RFK Jr.'s parasitic infection

Apple Watch's A

Dairy farmers resist CDC push for PPE against bird flu virus

After gene therapy, two congenitally deaf children hear for the first time

hotspot

focus

hotspot

knowledge